TABLE 4.
Results of time-kill studies for synergy
| Strain | Trovafloxacin + cefoperazone
|
Trovafloxacin + ceftazidime
|
Levofloxacin + cefoperazone
|
Levofloxacin + ceftazidime
|
Ciprofloxacin + cefoperazone
|
Ciprofloxacin + ceftazidime
|
Trovafloxacin + cefpirome
|
Trovafloxacin + gentamicin
|
Levofloxacin + cefpirome
|
Levofloxacin + gentamicin
|
Ciprofloxacin + cefpirome
|
Ciprofloxacin + gentamicin
|
||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ca | Tb | C | T | C | T | C | T | C | T | C | T | C | T | C | T | C | T | C | T | C | T | C | T | |
| 51 | A | 0.12/32 | A | 0.12/32 | S | 0.25/32 | A | 0.25/32 | S | A | A | A | A | 0.12/64 | A | 0.12/32 | A | 0.25/64 | A | 0.25/32 | A | 1/64 | A | 1/32 |
| 52 | A | 0.12/64 | S | 0.12/8 | S | 0.5/64 | S | 0.5/8 | S | 1/128 | S | 1/16 | S | 0.12/64 | A | 0.12/64 | S | 0.5/64 | A | 0.5/64 | A | A | A | 1/128 |
| 56 | S | 0.5/64 | S | 0.5/128 | A | 0.5/64 | S | 0.5/128 | A | A | A | 2/128 | S | 0.5/128 | A | 0.5/64 | A | 0.5/128 | A | 0.5/64 | A | 2/128 | A | 2/64 |
| 57 | A | 0.03/128 | S | 0.03/128 | A | 0.25/128 | A | 0.25/128 | A | 0.5/128 | A | 0.5/128 | S | 0.03/64 | A | 0.03/64 | A | 0.25/64 | A | 0.25/64 | A | 0.5/64 | A | 0.5/64 |
| 55 | A | 0.06/64 | S | 0.06/64 | A | 0.12/64 | S | 0.12/64 | A | 0.25/64 | S | 0.25/64 | S | 0.06/16 | A | 0.06/16 | A | 0.12/16 | A | 0.12/16 | A | 0.25/16 | A | 0.12/16 |
| 60 | S | A | S | 0.016/2 | A | A | S | 0.06/2 | A | A | S | 0.25/2 | S | 0.016/64 | S | 0.016/32 | A | 0.06/64 | S | 0.06/32 | A | 0.25/64 | S | 0.25/32 |
| 2 | A | 0.12/32 | A | 0.12/1 | A | 0.25/32 | A | 0.25/1 | A | 0.5/32 | A | 0.5/1 | A | 0.12/8 | A | 0.12/2 | A | A | A | 0.25/2 | A | 0.5/8 | A | 0.5/2 |
| 27 | S | 0.12/64 | S | 0.12/32 | S | 0.5/64 | S | 0.5/32 | S | 1/64 | S | 1/32 | S | 0.12/64 | A | 0.12/32 | S | 0.5/64 | A | 0.5/32 | S | 1/64 | A | 1/32 |
| 28 | A | 0.06/64 | S | 0.06/32 | A | 0.12/64 | A | 0.12/32 | S | 0.5/64 | S | 0.5/32 | S | 0.06/64 | A | A | A | 0.12/64 | A | A | A | 0.5/64 | A | 0.5/1 |
| 30 | S | 0.12/32 | S | 0.12/16 | S | 0.25/32 | S | 0.25/16 | S | 0.5/32 | S | 0.5/16 | S | 0.12/32 | S | 0.12/8 | S | 0.25/32 | S | 0.25/8 | S | 0.5/32 | S | 0.5/8 |
| 32 | A | 0.12/32 | S | 0.12/16 | A | 0.25/32 | A | 0.25/16 | A | 0.5/32 | A | 0.5/16 | S | 0.12/32 | A | A | A | 0.25/32 | A | A | A | A | A | A |
| 61 | S | 0.03/1 | A | 0.03/2 | A | A | A | 0.12/2 | S | 0.12/1 | A | 0.25/2 | A | 0.03/16 | A | A | S | 0.12/16 | A | A | A | 0.25/16 | S | 0.25/1 |
| 65 | A | 0.016/16 | A | 0.016/8 | A | A | A | 0.06/8 | S | 0.25/16 | A | 0.25/8 | A | 0.016/16 | A | A | A | 0.06/16 | A | A | S | 0.25/16 | A | A |
| 68 | S | 0.016/8 | A | A | A | 0.5/8 | A | 0.5/4 | S | 0.25/8 | A | A | A | A | A | 0.016/32 | S | 0.5/16 | A | 0.5/32 | S | 0.25/16 | A | A |
| 70 | A | 0.06/128 | A | 0.06/128 | A | 0.25/128 | A | 0.25/128 | A | 0.5/128 | A | 0.5/128 | A | 0.06/64 | A | A | A | 0.25/64 | A | A | A | 0.5/64 | A | A |
| 73 | S | 0.12/16 | S | 0.12/16 | S | 0.5/16 | A | A | S | 0.5/16 | S | 0.5/16 | S | 0.12/16 | A | A | S | 0.5/16 | A | A | A | A | A | A |
| 75 | S | 0.016/0.25 | S | 0.016/1 | S | 0.12/1 | A | 0.12/0.25 | A | 1/1 | A | 1/0.25 | S | 0.016/8 | S | 0.016/0.25 | A | A | S | 0.12/0.25 | A | 1/8 | S | 1/0.25 |
| 77 | A | 0.016/1 | A | 0.016/4 | A | 0.12/1 | A | 0.12/4 | A | 0.5/1 | A | 0.5/4 | A | 0.016/64 | A | 0.016/0.25 | A | A | A | 0.12/0.25 | A | A | A | 0.5/0.25 |
| 82 | A | 0.25/64 | S | 0.25/4 | A | 0.5/64 | S | 0.5/4 | A | 1/64 | S | 1/4 | S | 0.25/64 | A | A | A | 0.5/64 | A | A | A | 1/64 | A | 1/32 |
| 90 | A | A | A | 0.004/0.25 | A | A | A | A | A | A | A | A | A | 0.004/1 | A | 0.004/2 | S | 0.03/1 | A | 0.03/2 | A | A | S | 0.06/2 |
C, checkerboard titration; S, synergy; A, additivity or indifference.
T, time-kill method; the lowest concentration (in micrograms per milliliter) of each compound in the combination yielding sustained bactericidal activity (≥100-fold decrease in viable count) at 12 h compared to the concentration (in micrograms per milliliter) of the more active drug. A, additive.